The board of the Waterbeach-based cell engineering specialist say the company is ready for a US listing.
When the R&D Centre opens, the courtyard will be open to the public.
Director Adam Nethersole discusses how the pandemic has highlighted the importance of HPC for the sector.
The new partnership will enable new cell therapies and even accelerate prototype organ printing.
The Cambridge-based biopharma company wants to advance earlier diagnosis or slow the progression of chronic kidney disease.
One of them has the ‘potential to improve not only the quality and the length of life for millions’.
The v-SCREEN test invented by Prof Ray Iles, working with a University of Cambridge lab, could be a game-changer.
It is continuing to work with the UK government’s CONDOR programme for approval for diagnostic use.
It raises hopes of effective new therapies.
The Granta Park-based genomic sequencing giant expects a commercial launch in 2021.
